Executive Team

Carlos Castro Gonzalez, PhDChief Executive Officer

Ian Butterworth, MScChief Technical Officer

Measurement systems expert. Developed hardware and software for four prior medical device start-ups

Aurelien Bourquard, PhDChief Data Scientist

Designed cutting-edge AI and computer vision methods for biomedical imaging

Alvaro Sanchez-Ferro, MDChief Medical Officer

Led numerous human studies for clinical validation of new technologies

Business Development and Engineering

Alberto Pablo TrinidadSoftware Engineer

Developer of deep learning and computer vision algorithms

Dana Al-Ansari, MBABusiness Analyst

Developed customer insights and use-case validation for neutropenia detecting technologies

Awards and Support

1st place Diamond Prize winner 2018

1ST PLACE WINNER $200K COMPETITION 2018,

ACCELERATOR PARTICIPANT

$30K "PATIENT-PHYSICIAN RELATIONS" WINNER

PARTICIPANT

$12k "Innovatech" award

ACCELERATOR PARTICIPANT

$25k RICE BROWN SCHOOL OF ENGINEERING TECH INNOVATION PRIZE

$10k "impacto salud" award

Our Origin Story

Leuko is a company that spun out from the Massachusetts Institute of Technology and the Madrid–MIT M+Visión Consortium. The founders were research fellows in a biomedical technology innovation initiative who felt compelled to solve a big unmet medical need for cancer patients undergoing chemotherapy.